15 March 2009 in Nature Cell Biology
JMY, originally discovered as a binding partner of the p53 co-activator p300, is an actin-nucleating protein, assembling filaments both by activation of the Arp2/3 complex and through an Arp2/3-independent mechanism. Many cellular structures are assembled from networks of actin filaments, and the architecture of these networks depends on the mechanism by which the filaments are formed. Several classes of proteins are known to assemble new filaments, including the Arp2/3 complex, which creates branched filament networks, and Spire, which creates unbranched filaments1,2. We find that JMY, a vertebrate protein first identified as a transcriptional co-activator of p53, combines these two nucleating activities by both activating Arp2/3 and assembling filaments directly using a Spire-like mechanism. Increased levels of JMY expression enhance motility, whereas loss of JMY slows cell migration. When slowly migrating HL-60 cells are differentiated into highly motile neutrophil-like cells, JMY moves from the nucleus to the cytoplasm and is concentrated at the leading edge. Thus, JMY represents a new class of multifunctional actin assembly factor whose activity is regulated, at least in part, by sequestration in the nucleus.
10 February 2012 in The EMBO Journal
E2F transcription factors are implicated in diverse cellular functions. The founding member, E2F‐1, is endowed with contradictory activities, being able to promote cell‐cycle progression and induce apoptosis. However, the mechanisms that underlie the opposing outcomes of E2F‐1 activation remain largely unknown. We show here that E2F‐1 is directly methylated by PRMT5 (protein arginine methyltransferase 5), and that arginine methylation is responsible for regulating its biochemical and functional properties, which impacts on E2F‐1‐dependent growth control. Thus, depleting PRMT5 causes increased E2F‐1 protein levels, which coincides with decreased growth rate and associated apoptosis. Arginine methylation influences E2F‐1 protein stability, and the enhanced transcription of a variety of downstream target genes reflects increased E2F‐1 DNA‐binding activity. Importantly, E2F‐1 is methylated in tumour cells, and a reduced level of methylation is evident under DNA damage conditions that allow E2F‐1 stabilization and give rise to apoptosis. Significantly, in a subgroup of colorectal cancer, high levels of PRMT5 frequently coincide with low levels of E2F‐1 and reflect a poor clinical outcome. Our results establish that arginine methylation regulates the biological activity of E2F‐1 activity, and raise the possibility that arginine methylation contributes to tumourigenesis by influencing the E2F pathway.
18 January 2008 in EMBO Reports
Here, we report that the two recently identified E2F subunits, E2F7 and E2F8, are induced in cells treated with DNA‐damaging agents where they have an important role in dictating the outcome of the DNA‐damage response. The DNA‐damage‐dependent induction coincides with the binding of E2F7 and E2F8 to the promoters of certain E2F‐responsive genes, most notably that of the E2F1 gene, in which E2F7 and E2F8 coexist in a DNA‐binding complex. As a consequence, E2F7 and E2F8 repress E2F target genes, such as E2F1, and reducing the level of each subunit results in an increase in E2F1 expression and activity. Importantly, depletion of either E2F7 or E2F8 prevents the cell‐cycle effects that occur in response to DNA damage. Thus, E2F7 and E2F8 act upstream of E2F1, and influence the ability of cells to undergo a DNA‐damage response. E2F7 and E2F8, therefore, underpin the DNA‐damage response.
1 March 2003 in Journal of Cell Science
Previously, we identified TES as a novel candidate tumour suppressor gene that mapped to human chromosome 7q31.1. In this report we demonstrate that the TES protein is localised at focal adhesions, actin stress fibres and areas of cell-cell contact. TES has three C-terminal LIM domains that appear to be important for focal adhesion targeting. Additionally, the N-terminal region is important for targeting TES to actin stress fibres. Yeast two-hybrid and biochemical analyses yielded interactions with several focal adhesion and/or cytoskeletal proteins including mena, zyxin and talin. The fact that TES localises to regions of cell adhesion suggests that it functions in events related to cell motility and adhesion. In support of this, we demonstrate that fibroblasts stably overexpressing TES have an increased ability to spread on fibronectin.
24 November 2009 in Proceedings of the National Academy of Sciences
Despite its obvious importance in tumorigenesis, little information is available on the mechanisms that integrate cell motility and adhesion with nuclear events. JMY is a transcription co-factor that regulates the p53 response. In addition, JMY contains a series of WH2 domains that facilitate in vitro actin nucleation. We show here that the ability of JMY to influence cell motility is dependent, in part, on its control of cadherin expression as well as the WH2 domains. In DNA damage conditions JMY undergoes nuclear accumulation, which drives the p53 transcription response but reduces its influence on cell motility. Consequently, the role of JMY in actin nucleation is less in damaged cells, although the WH2 domains remain functional in the nucleus where they impact on p53 activity. Together, these findings demonstrate a pathway that links the cytoskeleton with the p53 response, and further suggest that the ability of JMY to regulate actin and cadherin is instrumental in coordinating cell motility with the p53 response.
1 May 2001 in American Journal of Physiology-Lung Cellular and Molecular Physiology
In severe or chronic asthma, there is an increase in airway smooth muscle cell (ASMC) mass as well as an increase in connective tissue proteins in the smooth muscle layer of airways. Transforming growth factor-β (TGF-β) exists in three isoforms in mammals and is a potent regulator of connective tissue protein synthesis. Using immunohistochemistry, we had previously demonstrated that ASMCs contain large quantities of TGF-β1–3. In this study, we demonstrate that bovine ASMC-derived TGF-β associates with the TGF-β latency binding protein-1 (LTBP-1) expressed by the same cells. The TGF-β associated with LTBP-1 localizes TGF-β extracellularly. Furthermore, plasmin, a serine protease, regulates the secretion of a biologically active form of TGF-β by ASMCs as well as the release of extracellular TGF-β. The biologically active TGF-β released by plasmin induces ASMCs to synthesize collagen I in an autocrine manner. The autocrine induction of collagen expression by ASMCs may contribute to the irreversible fibrosis and remodeling seen in the airways of some asthmatics.